Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$7.35 - $10.81 $498,072 - $732,539
-67,765 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$8.38 - $17.34 $9,000 - $18,623
-1,074 Reduced 1.56%
67,765 $705,000
Q4 2019

Feb 13, 2020

SELL
$11.18 - $18.6 $6,953 - $11,569
-622 Reduced 0.9%
68,839 $1.23 Million
Q3 2019

Nov 13, 2019

SELL
$12.09 - $20.46 $1.25 Million - $2.12 Million
-103,632 Reduced 59.87%
69,461 $867,000
Q2 2019

Aug 08, 2019

SELL
$18.5 - $25.47 $33,078 - $45,540
-1,788 Reduced 1.02%
173,093 $3.43 Million
Q1 2019

May 13, 2019

SELL
$14.62 - $22.13 $485,588 - $735,025
-33,214 Reduced 15.96%
174,881 $3.68 Million
Q4 2018

Feb 14, 2019

SELL
$17.09 - $38.25 $42,434 - $94,974
-2,483 Reduced 1.18%
208,095 $4.25 Million
Q3 2018

Nov 13, 2018

BUY
$34.05 - $55.9 $1.16 Million - $1.91 Million
34,176 Added 19.37%
210,578 $7.76 Million
Q2 2018

Aug 13, 2018

SELL
$36.15 - $52.5 $2.02 Million - $2.93 Million
-55,826 Reduced 24.04%
176,402 $8.86 Million
Q1 2018

May 14, 2018

SELL
$24.4 - $40.25 $569,325 - $939,153
-23,333 Reduced 9.13%
232,228 $8.48 Million
Q4 2017

Feb 13, 2018

SELL
$18.5 - $28.6 $91,075 - $140,797
-4,923 Reduced 1.89%
255,561 $7.23 Million
Q3 2017

Nov 13, 2017

BUY
$14.65 - $19.35 $43,642 - $57,643
2,979 Added 1.16%
260,484 $5.04 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-6,015 Reduced 2.28%
257,505 $4.31 Million
Q1 2017

Apr 17, 2019

BUY
N/A
4,241 Added 1.64%
263,520 $2.75 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-41,906 Reduced 13.91%
259,279 $2.33 Million
Q3 2016

Apr 17, 2019

BUY
N/A
301,185
301,185 $2.72 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $749M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.